CBAI in Argentina must be something to it. Here's CORD:USE trying to promote family-related banking services in Argentina boasting it has family-related banks in 38 countries!
((Look below... Don't know what it means other than it is a very bold statement supporting major International support for family-related banking by CORD:USE... the same that recently opened a family-related bank in NC June 2010))
Above all things our commitment is to truth. Dr. Carlos Carrere, Presidente de Bioprocrearte SA Dr. Carlos Carrere, President of SA Bioprocrearte Argentina
Bioprocrearte Procrearte and are above all things scientific medical institutions with over 10 years of experience in the field of reproductive medicine highly complex and cryo-preservation of umbilical cord stem cells.
We are dedicated to work with seriousness and responsibility, and this has led us to be the largest institution of Argentina in our areas. We work with honesty and dedication, and these attributes are likely to be, those who make us increasingly chosen by patients and parents who feel that stem cells keep their unborn children, is a very private and personal, as well, an act of love and responsibility.
However, at the continuing adverse opinions on the cryopreservation of cord stem cells and the use and usefulness of them, made some time ago by the INCUCAI or by certain groups or professionals who respond to them, I express my views respect and also I have translated two articles that will help them think ...
I remember as a child the discussion between the public and private education and those studying at a private school "bought the title," the same is said of private practice with regard to public health punished. However, many of our politicians who are tearing the cover for the public, send their children to schools and / or private universities or do not hesitate to resort to private practice on the public when one of them or their relatives have an accident or illness.
This double discourse, that misrepresentation continuous, which we are known, is one reason, without doubt the problems we have to grow as a society, not knowing that we respect, trying to override the rights and freedoms of others.
Stem cells have a disruptive potential, this means you can change not only medicine but politics and society in the future, as disruptive industrial development, the fall of the Berlin Wall, or the discovery of penicillin, among other things.
Faced with a possible change of this magnitude, there are other prospective and retrospective attitudes, or even retrograde, as the current attitude of INCUCAI, trampled the basic rights of individuals or of our population, claiming the donation compulsive, or trying to seize those stem cells kept to protect the health of their children, to pass to a public bank and where it is assumed international marketing.
Justice got different brakes on this outrage, but the attack continues, trying in one way or another affect our mission, and maliciously hindering and misinforming the public. It is clear that if the stem cells serve not to be used in an autologous manner, nor would it be useful to be exploited for allogeneic transplants. In addition to be a Public Bank Umbilical Cord Stem Cells in the Hospital Garrahan.
For that reason, I am interested in bringing my opinion, since we have been observing, that for different interests, some medical societies or medical issue opinions on the storage of cord blood for their own use or family, ignoring the growing use of blood cord for their own use, mainly for regenerative medicine, are not giving recommendations based on current evidence.
Transcribed below, a paper presented in May 2010, at the International Conference on Cell Therapy in Philadelphia, United States, as well as information translated from Cord:Use, United States, so that each one of you can establish your own analysis.
Sincerely. Dr. Carlos Carrere. Dr. Carlos Carrere. Presidente de Bioprocrearte SA President of SA Bioprocrearte
THE GROWTH OF CORD BLOOD USE. THE GROWTH OF CORD BLOOD USE. F. F. Verter, PhD, Parent's Guide to Cord Blood Foundation JJ Nietfeld, PhD, Dept. of Pathology, Univ. Medical Center Utrecht, Netherlands JJ Nietfeld, PhD, Dept. of Pathology, University Medical Center Utrecht, Netherlands The growth in the use of cord blood.
Background and Data:
The significance of autologous cord blood is a constant theme in debate. Therefore, we compared the growth rates of autologous versus allogeneic cord blood. Foundation Parent's Guide to Cord Blood maintains the unique international database of children who received treatment Before 2005, there were few cases per year of children who used their own cord blood because of indications in solid tumors or immune conditions.
Since 2005, infusions of cord blood has started to be used for treatments in regenerative medicine, in pilot form in which it is hoped that the infusion of stem cells from cord blood helps the patient's body to repair itself. Towards the end of 2009, the database had listed 211 autologous treatments worldwide, of which 73% took place in 2008 and 2009.
The graphs show the poster, abstract 211 cumulative cases through the end of 2009 by indications, treatment centers and family Bank Cord Blood.
To date, allogeneic cord blood has been almost totally for stem cell transplantation. The indications for transplantation of stem cells from cord blood are malignancies of the blood or immune system, inherited blood disorders and metabolic diseases. The Association of Bone Marrow Donors database has the largest international cord blood transplant. Its most recent annual report covers cord blood transplants, until 2008, the year in which there were 2825 transplants.
In his report of 2009, Rocha and Gluckman (Novus Sanguis), estimated that the cumulative number of allogeneic blood transplant International cord level would have exceeded 20,000.
Family Cord Blood Bank. About CORD USE - Family Cord Blood Bank. Bank Cord Blood Family, CORD: USE is led by an outstanding team of world leaders in storage, research and cord blood transplantation. We encourage all waiting to be parents, they search the Internet with team names CORD: USE or to see how the team CORD: USE has contributed to the history of storage and transplantation of cord blood.
You'll find the team CORD: USE is composed of many of the pioneers in the field of cord blood transplants, leading scientists in cord blood, the world's leading exponents of transplants and many of those recognized as the most outstanding world experts in cord blood.
Team Experts CORD: USE have an experience based on thousands of cord blood transplantation. The founder of the Bank Cord Blood Family CORD: USE, Dr. Hal Broxmeyer is internationally recognized as a pioneer in the field of storage and transplantation of stem cells from cord blood. He has authored over 600 publications on stem cell research cord blood. He is president of the American Society of Hematology ("ASH"), the largest professional association in the world with more than 16,000 members from 97 countries, dedicated to the causes and treatment of diseases of the blood.
The medical director of the Bank Cord Blood Family CORD: USE is Dr. Joanne Kurtzberg, recognized as one of the most experienced medical cord blood transplant and renowned expert on the subject. He conducted the first successful allogeneic cord blood in the world in 1993. Under his leadership, the Program for Blood and Marrow Transplant Pediatric Duke University has conducted approximately 1,000 cord blood transplant, having performed more transplants in children than any other program worldwide. It is co-director of the Consultative Group on Cord Blood National Marrow Donor and a member of the Advisory Council on Blood Stem Cell Transplantation.
The Director of the Bank Cord Blood Family CORD: USE is Dr. Alan Levine, former director of the Programme of Blood Diseases, National Institute of Health, based at the National Heart, Lung and Blood Institute (NHLBI "). Dr. Levine established research programs in Bone Marrow and Cord Blood in the NHLB1 and under his direction started the first blood storage program with federal funding. He has received numerous honors and awards because of his achievements in the direction of multi-national programs in hematological research.
Chief Scientific Advisor CORD: USE is Dr. John E. Wagner, is Director of Pediatric Hematology and Oncology and Blood and Marrow Transplantation and Scientific Director of Clinical Research Stem Cell Institute at the University of Minnesota, one of the busiest transplant centers in the country, with nearly 1000 blood transplants cord, having performed more transplants in adults than any other program worldwide. He and his team were the first to use umbilical cord blood in leukemia treatment in 1990 and discovered that two units of cord blood could be used partly compatible, no problem to treat larger patients for whom a single unit was not enough.
The Director of International Operations of CORD: USE is Dr. Eliane Gluckman, a professor of hematology at the University of Paris VII. He conducted the first successful cord blood transplant in the world in Paris in 1988 and has authored over 700 publications. Eurocard is President of the International Registry Cord Blood Transplantation involving 47 countries and is President of the European School of Haematology.
FINAL CONCLUSION: Umbilical cord blood contains valuable cells, stem cells that can multiply and grow with those that can cure serious and sometimes fatal diseases.
These cells are used in the treatment of more than 70 different diseases, and research in new applications is steadily growing. At present, only in America, more than 3,000 clinical trials are being developed. (*)
**The world's top scientists in the field of stem cells from umbilical cord blood, have decided to install the family bank CORD: USE, with presence in over 38 countries. You definitely have bet that this present, but above all things the future. Like all Bioprocrearte professionals, and surely many of you.
However, some scientists think Argentines are not the same and seem to want to own the truth. The global reality and the future, seem to go against his words and interests.
Dr. Carlos Carrere. Dr. Carlos Carrere. Presidente de Bioprocrearte. President of Bioprocrearte.
Market Data 
Markets 
AI
